Prothrombin complex concentrat (Taibang Biological Products)

人凝血酶原复合物（泰邦生物制品）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameProthrombin complex concentrat (Taibang Biological Products)
Drug Alias NamePCC-China Biologic Products人凝血酶原复合物生物人凝血酶原复合物生物类似物
ClassificationBiologics > Blood componentsBiologics > Biosimilar
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageAntithrombin III Deficiency
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date2014/09/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Taibang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Taibang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsAntithrombin III Deficiency

Other Information

ATC CodeB02BD01
Related LinksN/A